Treats hypertension. ANDA 76820, held by Amneal Pharms. Benazepril Hydrochloride.
As of Nov 16, 2026, ANDA 76820 (Benazepril Hydrochloride), held by Amneal Pharms, was first approved by FDA on Feb 3, 2006, with 9 approved supplements and 0 published complete response letters.
Benazepril HCl tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 3, 2006 | Original application | Approved | None posted |
| Benazepril Hydrochloride5MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride10MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride20MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride40MG · tablet;oral | Benazepril Hydrochloride | Rx |
| May 19, 2019 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jul 30, 2018 | Supplement 17Labeling · Standard review | Approved | None posted |
| Oct 19, 2015 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 22, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 22, 2015 | Supplement 12Labeling · Standard review | Approved | None posted |
| Nov 8, 2012 | Supplement 11Labeling · Standard review | Approved | None posted |
| Nov 8, 2012 | Supplement 10Labeling | Approved | None posted |
| Jan 29, 2010 | Supplement 8Labeling | Approved | None posted |
| Jul 23, 2009 | Supplement 4Labeling | Approved | None posted |
| Feb 3, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters